126 related articles for article (PubMed ID: 17437160)
1. A novel mutation in the LRP5 gene is associated with osteoporosis-pseudoglioma syndrome.
Barros ER; Dias da Silva MR; Kunii IS; Hauache OM; Lazaretti-Castro M
Osteoporos Int; 2007 Jul; 18(7):1017-8. PubMed ID: 17437160
[No Abstract] [Full Text] [Related]
2. Familial exudative vitreoretinopathy and osteoporosis-pseudoglioma syndrome caused by a mutation in the LRP5 gene.
Drenser KA; Trese MT
Arch Ophthalmol; 2007 Mar; 125(3):431-2. PubMed ID: 17353424
[No Abstract] [Full Text] [Related]
3. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
Ai M; Heeger S; Bartels CF; Schelling DK;
Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis-pseudoglioma syndrome may not be caused by persistent fetal vasculature.
Blair MP; Shapiro MJ
Arch Ophthalmol; 2007 Mar; 125(3):432-3; author reply 433. PubMed ID: 17353427
[No Abstract] [Full Text] [Related]
5. Asymmetrical ocular involvement and persistent fetal vasculature in an adult with osteoporosis-pseudoglioma syndrome.
Lai TY; Wong VW; Lam DS
Arch Ophthalmol; 2006 Mar; 124(3):422-3. PubMed ID: 16534066
[No Abstract] [Full Text] [Related]
6. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
[TBL] [Abstract][Full Text] [Related]
7. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
[TBL] [Abstract][Full Text] [Related]
8. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
9. Persistent fetal vasculature.
Jampol LM
Arch Ophthalmol; 2007 Mar; 125(3):432. PubMed ID: 17353428
[No Abstract] [Full Text] [Related]
10. Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia.
Saarinen A; Saukkonen T; Kivelä T; Lahtinen U; Laine C; Somer M; Toiviainen-Salo S; Cole WG; Lehesjoki AE; Mäkitie O
Clin Endocrinol (Oxf); 2010 Apr; 72(4):481-8. PubMed ID: 19673927
[TBL] [Abstract][Full Text] [Related]
11. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
[TBL] [Abstract][Full Text] [Related]
12. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
Gong Y; Slee RB; Fukai N; Rawadi G; Roman-Roman S; Reginato AM; Wang H; Cundy T; Glorieux FH; Lev D; Zacharin M; Oexle K; Marcelino J; Suwairi W; Heeger S; Sabatakos G; Apte S; Adkins WN; Allgrove J; Arslan-Kirchner M; Batch JA; Beighton P; Black GC; Boles RG; Boon LM; Borrone C; Brunner HG; Carle GF; Dallapiccola B; De Paepe A; Floege B; Halfhide ML; Hall B; Hennekam RC; Hirose T; Jans A; Jüppner H; Kim CA; Keppler-Noreuil K; Kohlschuetter A; LaCombe D; Lambert M; Lemyre E; Letteboer T; Peltonen L; Ramesar RS; Romanengo M; Somer H; Steichen-Gersdorf E; Steinmann B; Sullivan B; Superti-Furga A; Swoboda W; van den Boogaard MJ; Van Hul W; Vikkula M; Votruba M; Zabel B; Garcia T; Baron R; Olsen BR; Warman ML;
Cell; 2001 Nov; 107(4):513-23. PubMed ID: 11719191
[TBL] [Abstract][Full Text] [Related]
13. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
[TBL] [Abstract][Full Text] [Related]
14. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats.
Chung BD; Kayserili H; Ai M; Freudenberg J; Uzümcü A; Uyguner O; Bartels CF; Höning S; Ramirez A; Hanisch FG; Nürnberg G; Nürnberg P; Warman ML; Wollnik B; Kubisch C; Netzer C
Hum Mutat; 2009 Apr; 30(4):641-8. PubMed ID: 19177549
[TBL] [Abstract][Full Text] [Related]
15. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
Balemans W; Van Hul W
Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
[TBL] [Abstract][Full Text] [Related]
16. Decreased bone density in carriers and patients of an Israeli family with the osteoporosis-pseudoglioma syndrome.
Lev D; Binson I; Foldes AJ; Watemberg N; Lerman-Sagie T
Isr Med Assoc J; 2003 Jun; 5(6):419-21. PubMed ID: 12841014
[TBL] [Abstract][Full Text] [Related]
17. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.
Hartikka H; Mäkitie O; Männikkö M; Doria AS; Daneman A; Cole WG; Ala-Kokko L; Sochett EB
J Bone Miner Res; 2005 May; 20(5):783-9. PubMed ID: 15824851
[TBL] [Abstract][Full Text] [Related]
19. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.
Van Wesenbeeck L; Cleiren E; Gram J; Beals RK; Bénichou O; Scopelliti D; Key L; Renton T; Bartels C; Gong Y; Warman ML; De Vernejoul MC; Bollerslev J; Van Hul W
Am J Hum Genet; 2003 Mar; 72(3):763-71. PubMed ID: 12579474
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
